Ganesh Benzoplast Ltd (GBL) has entered a definitive agreement to sell its liquid storage and rail logistics business to Cisternina Logistics Private Limited, backed by KKR, for Rs 1,154 crore. The deal includes storage assets at JNP, Goa, and Cochin ports. GBL will also secure a Rs 280 crore EPC contract from the buyer. Management intends to use the proceeds for a potential share buyback, capacity expansion in chemical manufacturing, and growing its trading division, signaling a major strategic shift for the company.
Ganesh Benzoplast Signs Rs 1,154 Crore Divestment Deal
Total consideration of Rs 1,154 crore for logistics assets; additional Rs 280 crore EPC contract secured.
Reader Takeaway: Divestment provides significant liquidity and potential buyback, but execution of the new manufacturing strategy remains critical.
What just happened
Ganesh Benzoplast Limited (GBL) has signed definitive agreements to transfer its Liquid Storage Tank (LST) business and Rail Logistics operations to Cisternina Logistics Private Limited (CLPL). CLPL is a platform backed by KKR. The assets involved include storage facilities at Jawaharlal Nehru Port (JNP), Goa Port, and Cochin Port, alongside the company’s stake in ILSL Rail Logistics Private Limited.
Why this matters
The deal provides an immediate liquidity boost of Rs 1,154 crore. Furthermore, the company has secured a Rs 280 crore EPC contract from the acquirer to build and expand infrastructure at the JNP facility over the next 18-24 months. This pivot shifts the company away from its traditional logistics-heavy model toward higher-margin chemical manufacturing and specialized EPC work.
Strategy and Use of Proceeds
Management has outlined a clear path for the capital. The funds are earmarked for:
- Implementing a potential share buyback to reward investors.
- Expanding manufacturing capacity for food preservatives, lube oil additives, and specialized chemicals.
- Scaling up chemical trading activities.
- Executing high-value EPC projects.
Risks to watch
Investors should monitor the regulatory and shareholder approval process, as the transaction is slated to close in tranches over the next 18-24 months. Any delays in receiving necessary clearances could impact the anticipated timeline for the proposed capital deployment and buyback.
What to track next
The market will look for clear timelines regarding the buyback announcement and updates on the capacity expansion projects in the chemical manufacturing division.